The Bioengineering Editorial Office retracts the article “Mycosynthesis of Hematite (α-Fe2O3) Nanoparticles Using Aspergillus niger and Their Antimicrobial and Photocatalytic Activities” [1] cited above.
Following publication, concerns were brought to the attention of the publisher regarding particle duplication within Figure 5A in this article [1].
Adhering to our complaints procedure, an investigation was conducted by the Editorial Office and the Editorial Board. While the authors cooperated with the Editorial Office during the investigation, they were unable to satisfactorily explain the particle duplication within Figure 5A, nor could the Editorial Board validate this image from the raw material provided. As a result, the Editorial Board were unable to confirm the reliability of the findings and subsequently decided to retract this article [1] as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30, accessed on 15 January 2025) and in line with the Committee on Publication Ethics retraction guidelines (https://publicationethics.org/retraction-guidelines, accessed on 15 January 2025).
This retraction was approved by the Editor-in-Chief of the journal Bioengineering.
The authors did not agree to this retraction.
Reference
- Saied, E.; Salem, S.S.; Al-Askar, A.A.; Elkady, F.M.; Arishi, A.A.; Hashem, A.H. RETRACTED: Mycosynthesis of Hematite (α-Fe2O3) Nanoparticles Using Aspergillus niger and Their Antimicrobial and Photocatalytic Activities. Bioengineering 2022, 9, 397. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).